Effect of CMF-chemotherapy on blood coagulation in patients with breast cancer

Archive of Oncology

Volumn 10, Issue 2, 2002, Pages 61-66

  Petrović, Dragana ^a  

^a Institute of Oncology Sremska Kamenica   (Yugoslavia)

Author keywords

Antineoplastic Agents; Blood Coagulation; Breast neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; ANTITHROMBIN III; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; D DIMER; FLUOROURACIL; METHOTREXATE; PROTEIN C; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; METASTASIS; RISK FACTOR; THROMBOSIS;

EID: 0036620034     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0202061P     Document Type: Article

References (32)

1. Paraneoplastic syndromes
2. Pathophysiology of the thrombophilic state in the cancer patient
3. Thrombosis and cancer
4. Venous thromboembolism and neoplasms
5. Cancer and venous thromboembolisam: An overview
6. Hemostatic abnormalities associated with cancer and its therapy
7. Thrombophilic state in breast cancer
8. Coagulation disorders in cancer patients: Possible opportunity for therapy
9. The thrombophilic state induced by therapeutic agents in the cancer patient
10. Venous thrombosis during multimodal treatment of primary breast carcinoma
11. Increase incidence of thromboembolism in Stage IV, breast cancer patinets treated with a five drug chemotherapy regimen
12. Cancer and thrombosis
13. Venous thromboembolism as a first manifestation of cancer
14. The hyprecoagulable state of cancer
15. Hiperkoagulabilnost i pojava tromboembolijskih komplikacija u obolelih od malignih neoplazmi u toku hemio i radiobiloške terapije
16. Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer
17. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients
18. Adjuvant CMF chemotherapy in patients with breast cancer-results on blood coagulation and fibrinolysis
19. A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy
20. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery
21. The thrombophilic state induced by therapeutic agents in the cancer patient
22. Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
23. Abnormal coagulation and deep venous thrombosis in patients with advanced cancer
24. Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer
25. Activated protein-C resistance in cancer patients
26. Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states
27. Chemotherapy for breast cancer decreases plasma protein C and protein S
28. The effect of very-low-dose warfarin on markers of hyprecoagulation in metastatic breast cancer: Results from a randomized trial
29. Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients
30. Expression of prothrombin fragment 1+2 in cancer tissue as an indicator of local activation of blood coagulation
31. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status